The Use of Transcranial Direct Current Stimulation in the Rehabilitation of Post-Stroke Dysphagia During the Subacute Phase in Hospitalized Patients: A Randomized Clinical Trial
NCT: NCT07732673 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose of this clinical trial is to determine whether the use of tDCS in dysphagia rehabilitation during the subacute phase of stroke assists in the recovery process while patients are still hospitalized. Patients aged 60 to 80 years who have suffered a stroke and are in the subacute phase of the disease, admitted to the hospital, will be recruited to receive tDCS application contralateral to the lesion for 10 sessions, combined with conventional speech-language therapy for swallowing rehabilitation. The primary question it aims to answer is whether the use of tDCS combined with swallowing rehabilitation accelerates recovery compared to conventional speech-language therapy alone.
Frequently Asked Questions
What is The Use of Transcranial Direct Current Stimulation in the Rehabilitation of Post-Stroke Dysphagia During the Subacute Phase in Hospitalized Patients: A Randomized Clinical Trial?
The Use of Transcranial Direct Current Stimulation in the Rehabilitation of Post-Stroke Dysphagia During the Subacute Phase in Hospitalized Patients: A Randomized Clinical Trial is a clinical trial registered under NCT07732673. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07732673?
The current status of NCT07732673 (The Use of Transcranial Direct Current Stimulation in the Rehabilitation of Post-Stroke Dysphagia During the Subacute Phase in Hospitalized Patients: A Randomized Clinical Trial) is: ACTIVE_NOT_RECRUITING.
When did The Use of Transcranial Direct Current Stimulation in the Rehabilitation of Post-Stroke Dysphagia During the Subacute Phase in Hospitalized Patients: A Randomized Clinical Trial start?
The Use of Transcranial Direct Current Stimulation in the Rehabilitation of Post-Stroke Dysphagia During the Subacute Phase in Hospitalized Patients: A Randomized Clinical Trial started on 2026-07-16.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.